Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment.
Histopathology
Radiotherapy
Sinonasal carcinomas
Sinonasal malignancies
Surgery
Treatment
Journal
Current oncology reports
ISSN: 1534-6269
Titre abrégé: Curr Oncol Rep
Pays: United States
ID NLM: 100888967
Informations de publication
Date de publication:
27 Jun 2024
27 Jun 2024
Historique:
accepted:
26
05
2024
medline:
27
6
2024
pubmed:
27
6
2024
entrez:
27
6
2024
Statut:
aheadofprint
Résumé
The purpose of this review is to analyze the diagnosis and treatments of the sinonasal malignant tumors throw systematic reviewed literature. The systematic review of the literature was performed according to PRISMA guidelines. Total 11,653 cases of five article were analyzed. The cohort of 3824 cases received appropriate treatment. The most frequent histotype of the group of sinonasal malignancies was squamous cell carcinoma. Squamous cell carcinoma was represented by 54%. The other histopathological subtypes were esthesioneuroblastoma with 9,9%, melanoma 9,8%, adenocarcinoma 7,5%, sarcoma 7,3%, adeno cystic carcinoma 7,1%, sinonasal undifferentiated carcinoma 3,9%, sinonasal neuroendocrine carcinoma 2,8% respectively. All 772 cases of total 3824 were treated only surgically. All 62 cases of total 3824 were treated without surgery, 20 cases with proton technique and SFUD, and 42 cases with proton technique and IMRT. The other 2990 cases of total 3824 were treated with multimodality treatment. The diagnosis and treatment of sinonasal cancers require a interdisciplinary approach and multimodality treatment.
Identifiants
pubmed: 38935225
doi: 10.1007/s11912-024-01566-x
pii: 10.1007/s11912-024-01566-x
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Thawani R, Kim MS, Arastu A, Feng Z, West MT, Taflin NF, Thein KZ, Li R, Geltzeiler M, Lee N, Fuller CD, Grandis JR, Floudas CS, Heinrich MC, Hanna E, Chandra RA. The contemporary management of cancers of the sinonasal tract in adults. CA Cancer J Clin. 2023;73(1):72–112. Epub 2022 Aug 2. PMID: 35916666; PMCID: PMC9840681.
doi: 10.3322/caac.21752
pubmed: 35916666
Bracigliano A, Tatangelo F, Perri F, Di Lorenzo G, Tafuto R, Ottaiano A, Clemente O, Barretta ML, Losito NS, Santorsola M, Tafuto S. Malignant sinonasal tumors: update on histological and clinical management. Curr Oncol. 2021;28(4):2420–38. https://doi.org/10.3390/curroncol28040222 . PMID: 34287240; PMCID: PMC8293118.
doi: 10.3390/curroncol28040222
pubmed: 34287240
pmcid: 8293118
Shirley Y. Su1 Diana Bell2 Ehab Y. Hanna1 Esthesioneuroblastoma, Neuroendocrine Carcinoma, and Sinonasal Undifferentiated Carcinoma: differentiation in diagnosis and. Treat Int Arch Otorhinolaryngol. 2014;18:S149–56.
doi: 10.1055/s-0034-1390014
Lucidi D, Cantaffa C, Miglio M, Spina F, Alicandri Ciufelli M, Marchioni A, Marchioni D. Tumors of the nose and paranasal sinuses: promoting factors and molecular mechanisms—a systematic review. Int J Mol Sci. Molecular and cytogenetic studies on the pathogenesis of these heterogeneous cancers are lagging behind. New clinical trials are needed to define new therapeutic strategies. 2023;24(3):2670. https://doi.org/10.3390/ijms24032670 .
Akay S, Pollard JH, Saad Eddin A, Alatoum A, Kandemirli S, Gholamrezanezhad A, Menda Y, Graham MM, Shariftabrizi A. PET/CT Imaging in Treatment Planning and Surveillance of Sinonasal Neoplasms. Cancers (Basel). 2023;15(15):3759. https://doi.org/10.3390/cancers15153759 . PMID: 37568575; PMCID: PMC10417627.
doi: 10.3390/cancers15153759
pubmed: 37568575
Peyraga G, Lafond C, Pointreau Y, Giraud P, Maingon P. Radiothérapie des cancers des cavités nasosinusiennes [Nasal cavity and paranasal sinus cancer]. Cancer Radiother. 2016;20 Suppl: S99-S103. French. https://doi.org/10.1016/j.canrad.2016.07.035 . Epub 2016 Aug 12. PMID: 27528562.
Bhasker S, Mallick S, Benson R, Bhanuprasad V, Sharma A, Thakar A. A multimodality approach to sinonasal undifferentiated carcinoma: a single institute experience. J Laryngol Otol. 2017;131(1):19–25. Epub 2016 Dec 12. PMID: 27938440.
doi: 10.1017/S0022215116009543
pubmed: 27938440
Gunaydin G, Gedik ME, Ayan S. Photodynamic therapy for the Treatment and Diagnosis of Cancer-A Review of the current clinical status. Front Chem. 2021;9:686303. https://doi.org/10.3389/fchem.2021.686303 . PMID: 34409014; PMCID: PMC8365093.
doi: 10.3389/fchem.2021.686303
pubmed: 34409014
pmcid: 8365093
Grin M, Suvorov N, Ostroverkhov P, Pogorilyy V, Kirin N, Popov A, Sazonova A, Filonenko E. Advantages of combined photodynamic therapy in the treatment of oncological diseases. Biophys Rev. 2022;14(4):941–63. https://doi.org/10.1007/s12551-022-00962-6 . PMID: 36124276; PMCID: PMC9481804.
doi: 10.1007/s12551-022-00962-6
pubmed: 36124276
pmcid: 9481804
Hermsen MA, Bossi P, Franchi A, Lechner M, Sinonasal Cancer. Improving classification, stratification and therapeutic options. Cancers (Basel). 2023;15(6):1675. https://doi.org/10.3390/cancers15061675 . PMID: 36980561; PMCID: PMC10046049.
doi: 10.3390/cancers15061675
pubmed: 36980561
Gautam U, Mehta SM, Rasa, Shirley Y, Su, Ehab Y, Hanna, Franco DeMonte. Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skull base. J Neurooncol. This group of sinonasal carcinoma which content neuroendocrine histological features require multimodality treatment. 2020;150(3):367–75. https://doi.org/10.1007/s11060-020-03537-1 .
Chitguppi C, Koszewski I, Collura K, Curtis M, Nyquist G, Rabinowitz M, Rosen M. Biphenotypic Sinonasal Sarcoma-Case Report and Review of Clinicopathological features and diagnostic modalities. J Neurol Surg B Skull Base. 2019;80(1):51–8. https://doi.org/10.1055/s-0038-1667146 . Epub 2018 Jul 16. PMID: 30733901; PMCID: PMC6365237.
doi: 10.1055/s-0038-1667146
pubmed: 30733901
Abdelmeguid AS, Bell D, Hanna EY. Sinonasal Undifferentiated Carcinoma. Curr Oncol Rep. 2019;21(3):26. https://doi.org/10.1007/s11912-019-0776-4 . PMID: 30806835.
Lasrado S, Naaz S, Moras K, D’Souza C, Loka SR. Analysis of disease patterns in patients with unilateral Sinonasal diseases: a Tertiary Care Hospital Experience. Indian J Otolaryngol Head Neck Surg. 2022;74(1):63–9. https://doi.org/10.1007/s12070-020-02266-1 . Epub 2021 Jan 3. PMID: 35070926; PMCID: PMC8743316.
doi: 10.1007/s12070-020-02266-1
pubmed: 35070926
Hart ZP, Nishio N, Krishnan G, Lu G, Zhou Q, Fakurnejad S, Wormald PJ, van den Berg NS, Rosenthal EL, Baik FM. Endoscopic fluorescence-guided surgery for Sinonasal Cancer using an antibody-dye Conjugate. Laryngoscope. 2020;130(12):2811–7. https://doi.org/10.1002/lary.28483 . Epub 2019 Dec 19. PMID: 31854462; PMCID: PMC7754277.
doi: 10.1002/lary.28483
pubmed: 31854462
Jafari A, Shen SA, Qualliotine JR, Orosco RK, Califano JA, DeConde AS. Impact of margin status on survival after surgery for sinonasal squamous cell carcinoma. Int Forum Allergy Rhinol. 2019;9(10):1205–11. https://doi.org/10.1002/alr.22415 . Epub 2019 Aug 22. PMID: 31436890.
doi: 10.1002/alr.22415
pubmed: 31436890
Lehrich BM, Yasaka TM, Goshtasbi K, Kuan EC. Outcomes of primary Versus salvage surgery for Sinonasal malignancies: a Population-based analysis. Laryngoscope. 2021;131(3):E710–8. https://doi.org/10.1002/lary.28925 . Epub 2020 Jul 24. PMID: 32706415.
doi: 10.1002/lary.28925
pubmed: 32706415
Kacorzyk U, Kentnowski M, Szymczyk C, Chmielik E, Bobek-Billewicz B, Składowski K, Rutkowski TW. Results of primary treatment and salvage treatment in the management of patients with non-squamous cell malignant tumors of the Sinonasal Region: single Institution experience. J Clin Med. 2023;12(5):1953. https://doi.org/10.3390/jcm12051953 . PMID: 36902738; PMCID: PMC10004315.
doi: 10.3390/jcm12051953
pubmed: 36902738
pmcid: 10004315
Torabi SJ, Spock T, Cardoso B, Chao J, Morse E, Manes RP, Judson BL. Margins in Sinonasal squamous cell carcinoma: predictors, outcomes, and the Endoscopic Approach. Laryngoscope. 2020;130(6):E388–96. https://doi.org/10.1002/lary.28315 . Epub 2019 Nov 22. PMID: 31755988.
doi: 10.1002/lary.28315
pubmed: 31755988
Nakamaru Y, Suzuki M, Kano S, Mizumachi T, Tsushima N, Suzuki T, Honma A, Nakazono A, Kimura S, Onimaru R, Yasuda K, Shirato H, Homma A. The role of endoscopic resection for selected patients with sinonasal squamous cell carcinoma. Auris Nasus Larynx. 2021;48(1):131–7. Epub 2020 Jul 25. PMID: 32723597.
doi: 10.1016/j.anl.2020.06.014
pubmed: 32723597
Anschuetz L, Hohenberger R, Kaecker C, Elicin O, Giger R, Caversaccio M. Sinonasal malignancies: histopathological entities, regional involvement and long-term outcome. J Otolaryngol Head Neck Surg. 2023;52(1):36. https://doi.org/10.1186/s40463-023-00627-8 . PMID: 37118840; PMCID: PMC10148547.
doi: 10.1186/s40463-023-00627-8
pubmed: 37118840
pmcid: 10148547
Fiani B, Quadri SA, Cathel A, Farooqui M, Ramachandran A, Siddiqi I, Ghanchi H, Zafar A, Berman BW, Siddiqi J. Esthesioneuroblastoma: a comprehensive review of diagnosis, management, and current treatment options. World Neurosurg. 2019;126:194–211. Epub 2019 Mar 9. PMID: 30862589.
doi: 10.1016/j.wneu.2019.03.014
pubmed: 30862589
Fang Y, Peng Z, Wang Y, Gao K, Liu Y, Fan R, Zhang H, Xie Z, Jiang W. Current opinions on diagnosis and treatment of adenoid cystic carcinoma. Oral Oncol. 2022;130:105945. https://doi.org/10.1016/j.oraloncology.2022.105945 . Epub 2022 Jun 2. PMID: 35662026.
doi: 10.1016/j.oraloncology.2022.105945
pubmed: 35662026
Siddiqui F, Smith RV, Yom SS, Beitler JJ, Busse PM, Cooper JS, Hanna EY, Jones CU, Koyfman SA, Quon H, Ridge JA, Saba NF, Worden F, Yao M, Salama JK. Expert Panel on Radiation Oncology - Head and Neck Cancer. ACR appropriateness criteria® nasal cavity and paranasal sinus cancers. Head Neck. 2017;39(3):407–18. https://doi.org/10.1002/hed.24639 . Epub 2016 Dec 29. PMID: 28032679.
doi: 10.1002/hed.24639
pubmed: 28032679
Robin TP, Jones BL, Gordon OM, Phan A, Abbott D, McDermott JD, Goddard JA, Raben D, Lanning RM, Karam SD. A comprehensive comparative analysis of treatment modalities for sinonasal malignancies. Cancer. 2017;123(16):3040–9. https://doi.org/10.1002/cncr.30686 . Epub 2017 Apr 3. PMID: 28369832; PMCID: PMC6234843.
doi: 10.1002/cncr.30686
pubmed: 28369832
Jeong Y, Lee SW, Kwak J, Cho I, Yoon SM, Kim JH, Park JH, Choi EK, Song SY, Kim YS, Kim SS, Joo JH, Ahn SD. A dosimetric comparison of volumetric modulated arc therapy (VMAT) and non-coplanar intensity modulated radiotherapy (IMRT) for nasal cavity and paranasal sinus cancer. Radiat Oncol. 2014;9:193. https://doi.org/10.1186/1748-717X-9-193 . PMID: 25175383; PMCID: PMC4261880.
doi: 10.1186/1748-717X-9-193
pubmed: 25175383
pmcid: 4261880
Biau J, Lapeyre M, Troussier I, Budach W, Giralt J, Grau C, Kazmierska J, Langendijk JA, Ozsahin M, O’Sullivan B, Bourhis J, Grégoire V. Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update. Radiother Oncol. 2019;134:1–9. Epub 2019 Jan 30. PMID: 31005201.
doi: 10.1016/j.radonc.2019.01.018
pubmed: 31005201
Duru Birgi S, Teo M, Dyker KE, Sen M, Prestwich RJ. Definitive and adjuvant radiotherapy for sinonasal squamous cell carcinomas: a single institutional experience. Radiat Oncol. 2015;10:190. https://doi.org/10.1186/s13014-015-0496-3 . PMID: 26377408; PMCID: PMC4574072.
doi: 10.1186/s13014-015-0496-3
pubmed: 26377408
pmcid: 4574072
Zhang B, Huang D, Liu J, Wu W, Zong L. Prognostic effects of surgery or radiotherapy on adenoid cystic carcinoma of the head and neck: a retrospective cohort study. Gland Surg. 2022;11(11):1784–94. https://doi.org/10.21037/gs-22-526 . PMID: 36518804; PMCID: PMC9742048.
doi: 10.21037/gs-22-526
pubmed: 36518804
pmcid: 9742048
Nakajima K, Iwata H, Hattori Y, Nomura K, Hashimoto S, Toshito T, Hayashi K, Kuroda Y, Fukano H, Ogino H, Shibamoto Y. Spot scanning Proton Therapy for Sinonasal Malignant tumors. Int J Part Ther. 2021;8(1):189–99. https://doi.org/10.14338/IJPT-D-20-00043.1 . PMID: 34285946; PMCID: PMC8270097.
doi: 10.14338/IJPT-D-20-00043.1
pubmed: 34285946
pmcid: 8270097
Hafström A, Sjövall J, Persson SS, Nilsson JS, Svensson C, Brun E, Greiff L. Outcome for sinonasal malignancies: a population-based survey. Eur Arch Otorhinolaryngol. 2022;279(5):2611–2622. https://doi.org/10.1007/s00405-021-07057-0 . Epub 2021 Sep 12. Erratum in: Eur Arch Otorhinolaryngol. 2022; PMID: 34510258; PMCID: PMC8986678.